Pharmafile Logo
Pharmafocus logo
Advanced Search
Blood clot

Phase III success for apixaban

March 5, 2010
Research and Development BMS, Pfizer, VTE, apixaban

Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …

News
MabThera

Roche cancer drug gets NICE thumbs up

March 5, 2010
Sales and Marketing MabThera, Roche

NICE has recommended Roche’s MabThera to treat patients with the most common form of leukaemia, relapsed or refractory chronic lymphocytic …

News

FDA encourages cell-based vaccine production

March 5, 2010
Manufacturing and Production h1n1, swine flu

The US Food and Drug Administration has issued a new guidance document designed to help encourage the adoption of cell-based …

News

Sudler & Hennessey London expands

March 5, 2010
Medical Communications Sudler & Hennessey, appointments, medical communications

Sudler & Hennessey London has added ten new members to its team, expanding its account handling and creative departments. Group …

Appointment

NICE asks Roche for RoActemra cost data

March 5, 2010
Sales and Marketing RoActemra, Roche

Roche’s attempts to secure NICE approval for rheumatoid arthritis drug RoActemra have hit another hurdle. NICE’s independent appraisal committee has …

News

Merck appoints Bridgette Heller

March 5, 2010
Sales and Marketing Merck, appointment, consumer healthcare, sales and marketing

Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care. She moves to Merck …

Appointment
FPA logo

Just teams up with sexual health charity

March 5, 2010
Medical Communications FPA, charity, contraception, just health pr

Just Health PR is providing PR support for the launch of a new UK consumer book on contraception from sexual …

News

Kantar Health promotes Ceri Thomas

March 4, 2010
Sales and Marketing Kantar Health, appointment, sales and marketing

Ceri Thomas has been promoted to head of global marketing at healthcare consultancy and marketing insights company Kantar Health. In …

Appointment

Pfizer suffers Alzheimer’s setback

March 4, 2010
Research and Development Alzheimer's, Medivation, Pfizer

Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …

News
HCA report

HCA: Five years of change in healthcare communications

March 4, 2010
Medical Communications HCA, industry reputation

In 2005 the Healthcare Communications Association (HCA) conducted its first ever benchmarking survey, exploring trends in the provision of communications …

Feature
Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010
Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …

Appointment
Mario Nacinovich

Axon expands in the US

March 4, 2010
Medical Communications Axon, medical communications

Surrey, UK-based Axon Communications has appointed Mario Nacinovich as managing director of its new US operations. Nacinovich will be based …

News

Stem cell therapy helps diabetes limb problems

March 3, 2010
Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …

News
UCB

Generic Keppra hits UCB sales

March 3, 2010
Sales and Marketing 2009 financials, Keppra, UCB

UCB’s sales fell 13% in 2009 as the pharma company faced the first full year of generic competition in the …

News

Funds keep Archimedes Pharma buoyant

March 3, 2010
Research and Development Archimedes, funding

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …

News
Dementia strategy

Awareness push for dementia

March 3, 2010
dementia, disease awareness campaigns

The government’s offensive on dementia has continued with a new awareness campaign called Living Well, which aims to break down …

News

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010
Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …

News
OgilvyAdrianKemsley

Adrian Kemsley joins Ogilvy Healthworld

March 3, 2010
Medical Communications Ogilvy, appointment, medical communications, ogilvy healthworld advertising

Ogilvy Healthworld Advertising has appointed Adrian Kemsley as creative director and overall lead for the agency and unveiled a new …

Appointment

Dr Olaf Stange to head up Bayer Technology in Singapore

March 3, 2010
Manufacturing and Production Bayer Technology Services, appointment, manufacturing and production

Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) …

Appointment

Stability data issue holds up Adventrx cancer drug

March 3, 2010
Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine

US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025